Physicians Group Calls on the FDA to Repurpose Enbrel for the Treatment of TBI, Stroke and Alzheimers Disease
(PRWEB) February 06, 2013
The growing body of published observational data showing significant and rapid improvement in physical motor impairments, spasticity, memory and cognitive function following perispinal Enbrel treatment warrants the commencement of rigorous clinical trials leading to the repurposing of Enbrel for the treatment of traumatic brain injury (TBI), stroke and Alzheimers disease. Physicians Augusto Ramirez, M.D.CEO of Neurological Wellness Center: http://www.neurological-recovery-guide.com/, Eugenia Siezar, M.D. and Meylin Acuna, M.D. petition the FDA to take immediate steps leading to the repurposing of Enbrel for the treatment of TBI, stroke and Alzheimers disease.
Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua, Nicaragua authorized this press release.
Today Neurological Wellness Center remains the only institution in the world providing individualized instructional courses teaching this perispinal Enbrel injection procedure. For more information about Neurological Wellness Centers perispinal Enbrel injection courses, visit: http://reversealzheimersnow.com/